Athira Pharma, Inc. Common Stock (ATHA) Stock Price, Quote & AI Analysis

Live ATHA stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Athira Pharma, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Athira Pharma, Inc. Common Stock (NASDAQ: ATHA), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

ATHA
Athira Pharma, Inc. Common Stock
XNAS BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
real-time
$0.00 +0.00 (+0.00%)
Market Cap
$15,184,138.20
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 25, 2026 Q4
After Hours
EPS Estimate: $-0.8721
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Athira Pharma, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Athira Pharma, Inc. Common Stock Overview

Company information

Company Overview

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

Company Details
Market Cap
$15.18M
Weighted Shares Outstanding
3,943,932
Address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Phone
(425) 620-8501
Employees
26
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
XNAS
Listed
Sep 2020

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Athira Pharma, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...